Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07707531
EARLY_PHASE1
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer
Sponsor: Huashan Hospital
View on ClinicalTrials.gov
Summary
This study is to evaluate the safety, biodistribution, radiation dosimetry and tumor uptake of the \[68Ga\]/ \[131I\]-IR199 in patients with Claudin 18.2 positive gastric cancer and pancreatic cancer.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-06-01
Completion Date
2027-05-31
Last Updated
2026-07-16
Healthy Volunteers
No
Conditions
Interventions
DRUG
[68Ga]/ [131I]-IR199
\[68Ga\]/ \[131I\]-IR199, single dose
Locations (1)
Huashan Hospital
Shanghai, China